A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke

NCT05445895 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

483

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Renexin CR 200/160mg
DRUG: Plavix 75mg

Sponsor

SK Chemicals Co., Ltd.